AlphaYouKK
Insider selling
Kevin Koch sold $785K of Edgewise Therapeutics, Inc. (EWTX) stock
Kevin Koch, President and CEO of Edgewise Therapeutics, Inc. (EWTX), sold 17,971 shares of EWTX stock worth $785K, per an SEC Form 4 filed Aug 14, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 12, 2026, 2 days before it was made public.
EWTX has moved +2.2% since the trade date, from $43.56 to $44.51 (Sep 22, 2026 close).
- Traded
- Aug 12, 2026
- Disclosed
- Aug 14, 2026
- Filing delay
- 2 days
- Price since
- +2.2%
- Role
- President and CEO
- Source
- SEC Form 4
More EWTX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.